Dacogen, Lyophilisat zur Herstellung eines Konzentrats zur Herstellung einer Infusionslösung - Durchstechflasche(n) Swissmedic Key 62406001 Registration Holder Janssen-Cilag AG Name Dacogen, Lyophilisat zur Herstellung eines Konzentrats zur Herstellung einer Infusionslösung Date of registration 18.10.2012 Original/Generic Original Introduction of Sequence 18.10.2012 ATC-Classification Decitabine (L01BC08) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size Durchstechflasche(n) Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 890.92 Limitation Yes Limitation text
Deductible 10 % Consumer price 979.75 Feedback FB GTIN 7680624060012 Medication Code Synthetika Pharmacode 5422421 Disponibility
Composition Praeparatio cryodesiccata: decitabinum 50.00 mg, kalii dihydrogenophosphas corresp. kalium 19.53 mg, natrii hydroxidum corresp. natrium 6.67 mg, acidum hydrochloridum, pro vitro. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Excipiens BAG: Active Agent Dose 50 mg
Inactive agents Potassium Dihydrogenophosphate Sodium Hydroxide
Source Data was imported : 05.05.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
